COLUMBIA, Md., Dec. 3, 2013 /PRNewswire-iReach/ -- Seguro Surgical, Inc. ("Seguro") announced today that the rights to its novel surgical device, Lap Pak, have been acquired by The OR Company of Tacoma, WA. Terms of the acquisition were not disclosed.
Seguro, based in Columbia, MD, licensed the Lap Pak technology from Johns Hopkins University in 2009 and further developed the device with support from a grant from the Maryland Technology Development Corporation ("TEDCO").
Lap Pak is designed to replace the use of cotton towels to pack and secure the bowels during major open abdominal surgeries. Lap Pak is designed to reduce post-operative adhesions caused by the use of cotton towels, which cost the healthcare system $3 billion annually. The technology also saves significant OR time - approximately $1,000 savings per procedure.
Tony Deasey, CEO of Seguro, commented, "The success of Lap Pak to date has been a testament to the power of collaboration between innovative Maryland organizations like Johns Hopkins and TEDCO. With The OR Company's worldwide distribution capabilities, Lap Pak can now improve patient safety on a global scale."
About Seguro: Seguro is a medical device company that in-licenses and develops early stage medical device technologies that meet our mission of reducing health care costs while improving patient safety. For more information about Seguro visit www.segurosurgical.com
About The OR Company: The OR Company is a leading supplier of gynecologic and general surgery products focused on instrument organization, uterine manipulation and trans-vaginal access for laparoscopic surgery.
About the Maryland Technology Development Corporation (TEDCO): TEDCO is the go-to source for entrepreneurial support and guidance for start-ups and early-stage companies engaged in bringing innovative ideas to market. For more than a decade, the organization has provided funding, mentoring and networking opportunities to support Maryland's innovation ecosystem. While founded by the Maryland General Assembly, TEDCO is an independent entity that makes seed/early-stage investments and manages private capital for angel and venture capital funds. It is frequently ranked as one of the most active seed/early-stage investors in the nation. The organization plays a key role in bringing research created in Maryland's educational institutions and federal laboratories into the commercial marketplace. For more information on TEDCO and its programs and resources, visit www.TEDCO.md.
Media Contact: Anthony Deasey, Seguro Surgical, Inc., 4107722295, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
|SOURCE Seguro Surgical, Inc.|
Copyright©2012 PR Newswire.
All rights reserved